<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" specific-use="sps-1.6" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">rfmun</journal-id>
			<journal-title-group>
				<journal-title>Revista de la Facultad de Medicina</journal-title>
				<abbrev-journal-title abbrev-type="publisher">rev.fac.med.</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="ppub">0120-0011</issn>
			<publisher>
				<publisher-name>Universidad Nacional de Colombia</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="doi">10.15446/revfacmed.v66n1.59898</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Artículo de reflexión</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Cancer and mitochondrial function</article-title>
				<trans-title-group xml:lang="es">
					 <trans-title><italic>El cáncer en la función mitochondrial</italic></trans-title>  
				</trans-title-group>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Freyre-Bernal</surname>
						<given-names>Sofía Isabel</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Saavedra-Torres</surname>
						<given-names>Jhan Sebastian</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
					<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
					<xref ref-type="corresp" rid="c1"><sup>*</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Zúñiga-Cerón</surname>
						<given-names>Luisa Fernanda</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
					<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Díaz-Córdoba</surname>
						<given-names>Wilmer Jair</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
					<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Pinzón-Fernández</surname>
						<given-names>María Virginia</given-names>
					</name>
					<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>1</label>
				<institution content-type="original"> Universidad del Cauca - Faculty of Health Sciences - Department of Physiological Sciences - Popayán - Colombia.</institution>
				<institution content-type="normalized">Universidad del Cauca</institution>
				<institution content-type="orgname">Universidad del Cauca</institution>
				<institution content-type="orgdiv1">Faculty of Health Sciences</institution>
				<institution content-type="orgdiv2">Department of Physiological Sciences</institution>
				<addr-line>
					<named-content content-type="city">Popayán</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff2">
				<label>2</label>
				<institution content-type="original"> Corporación Del Laboratorio al Campo - Research Seedling Unit - Popayán - Colombia.</institution>
				<institution content-type="orgname">Corporación Del Laboratorio al Campo</institution>
				<addr-line>
					<named-content content-type="city">Popayán</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff3">
				<label>3</label>
				<institution content-type="original"> Universidad del Cauca - Faculty of Health Sciences - Health Research Group - Popayán - Colombia.</institution>
				<institution content-type="normalized">Universidad del Cauca</institution>
				<institution content-type="orgname">Universidad del Cauca</institution>
				<institution content-type="orgdiv1">Faculty of Health Sciences</institution>
				<institution content-type="orgdiv2">Health Research Group</institution>
				<addr-line>
					<named-content content-type="city">Popayán</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff4">
				<label>4</label>
				<institution content-type="original"> Universidad del Cauca - Faculty of Health Sciences - Internal Medicine Department - Popayán - Colombia.</institution>
				<institution content-type="normalized">Universidad del Cauca</institution>
				<institution content-type="orgname">Universidad del Cauca</institution>
				<institution content-type="orgdiv1">Faculty of Health Sciences</institution>
				<institution content-type="orgdiv2">Internal Medicine Department</institution>
				<addr-line>
					<named-content content-type="city">Popayán</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<author-notes>
				<corresp id="c1">
					<label>*</label> Corresponding author: Jhan Sebastian Saavedra-Torres. Health Research Group, Faculty of Health Sciences, Universidad del Cauca. Colombia, Cauca. Carrera 6 N° 13N-50 de Popayán, sector de La Estancia. Telephone number: 8209870-8209800 ext. 2717 Email: jhansaavedra@unicauca.edu.co.</corresp>
			</author-notes>
			<pub-date pub-type="epub-ppub">
				<season>Jan-Mar</season>
				<year>2018</year>
			</pub-date>
			<volume>66</volume>
			<issue>1</issue>
			<fpage>83</fpage>
			<lpage>86</lpage>
			<history>
				<date date-type="received">
					<day>03</day>
					<month>09</month>
					<year>2016</year>
				</date>
				<date date-type="accepted">
					<day>28</day>
					<month>10</month>
					<year>2016</year>
				</date>
			</history>
			<permissions>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/" xml:lang="en">
					<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
				</license>
			</permissions>
			<abstract>
				<title>Abstract</title>
				<p>Metabolism alterations are associated with the loss of mitochondrial function in tumor cells. Current research discuss whether such loss is evident in function itself, or if cells can provide maximum stability to its functions. More studies are needed to determine the behavior of cancer in mitochondria. Tumor cells experience a limitation of oxygen and mutations in oncogenes, tumor suppressor genes and enzymes of the glycolytic pathway and/or mitochondrial oxidative metabolism, thus allowing the formation of aggressive cancer. This article is the result of a literature review of the scientific evidence that has been presented in the latest research on cancer and mitochondrial function.</p>
			</abstract>
			<trans-abstract xml:lang="es">
				<title>Resumen</title>
				<p>Se ha descrito que algunas alteraciones del metabolismo están asociadas con la pérdida de función mitocondrial en células tumorales. Aún se discute si tal pérdida se evidencia en la función o si la célula brinda máxima estabilidad a sus funciones, se requieren más estudios para conocer el comportamiento del cáncer en la mitocondria. Cuando tiene limitación de oxígeno y mutaciones en oncogenes, genes supresores de tumor y enzimas de la vía glucolítica o del metabolismo oxidativo mitocondrial, la célula tumoral permite la formación de un cáncer agresivo. Este artículo es producto de la revisión bibliográfica de la evidencia científica que se ha presentado en las últimas investigaciones respecto al cáncer y la función mitocondrial.</p>
			</trans-abstract>
			<kwd-group xml:lang="en">
				<title>Keywords:</title>
				<kwd>Cancer</kwd>
				<kwd>Glycolysis</kwd>
				<kwd>Mitochondria</kwd>
				<kwd>Neovascularization pathologic (MeSH)</kwd>
			</kwd-group>
			<kwd-group xml:lang="es">
				<title>Palabras clave:</title>
				<kwd>Cáncer</kwd>
				<kwd>Mitocondria</kwd>
				<kwd>Neovascularización patológica</kwd>
				<kwd>Glucólisis (DeCS)</kwd>
			</kwd-group>
			<counts>
				<fig-count count="0"/>
				<table-count count="2"/>
				<equation-count count="0"/>
				<ref-count count="40"/>
				<page-count count="4"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<sec sec-type="intro">
			<title>Introduction</title>
			<p>The genes which encode the machinery that generates energy in the mitochondria are tumor suppressors; when they do not function properly, some processes and pathways that lead to cancer may be triggered. Mitochondria are organelles that have mitochondrial DNA (mtDNA), which is inherited only from the mother during the fertilization process. These organelles are the &quot;energetic generators&quot; of healthy cells, such as those that have their metabolisms encoded to be apoptosis inhibitors. <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B2"><sup>2</sup></xref>
			</p>
			<p>Mitochondria regulate and coordinate apoptosis activation, hence their importance for the study and research on therapies against cancer. When mitochondria deregulate, the onset of diseases such as cancer is stimulated due to an increased catabolic process, not to mention their role in neurodegenerative diseases, which are associated with abnormal mitochondrial function and apoptosis. <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B2"><sup>2</sup></xref>
			</p>
			<sec>
				<title>Mitochondria and cancer</title>
				<p>mtDNA mutagenesis is involved in a wide arrange of tumor processes, including renal adenocarcinoma, colon cancer, head and neck tumors, astrocytic tumors, thyroid tumors, breast tumors, ovarian, prostate and bladder cancer tumors, neuroblastomas, and oncocytomas. Many mtDNA mutations in cancer cells clearly inhibit oxidative phosphorylation. Although some of these cancers have ancestral polymorphisms associations, others may be cancer cell mutations. <xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref> (<xref ref-type="table" rid="t1">table 1</xref>).</p>
				<p>
					<table-wrap id="t1">
						<label>Table 1</label>
						<caption>
							<title>Generalities of the role of cancer in mitochondrial function. cases, cancer patients with localized tumors have a better survival</title>
						</caption>
						<graphic xlink:href="0120-0011-rfmun-66-01-00083-gt1.png"/>
						<table-wrap-foot>
							<fn id="TFN1">
								<p>Source: Own elaboration based on the data obtained in the study.</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
				<p>Cancer cells acquire enough ATP to support proliferation and to function endlessly, which has captivated scientists for nearly a century. Otto Warburg <italic>et al.</italic> conducted the first quantitative study on cancer cell metabolism in the 1920s. <xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref>
				</p>
				<p>Cells can obtain energy through a process called glycolysis that consists of anaerobic fermentation, in which the waste products of that fermentative process are pyruvate and lactic acid. <xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref> Tumor tissues metabolize approximately ten times more glucose into lactate at a given time than normal tissues. <xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref> Warburg hypothesized that effective cellular respiration caused by mitochondrial damage leads to carcinogenesis. <xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref>
				</p>
				<p>Warburg’s effect describes that cancer cells use glycolysis followed by lactic fermentation as an energy source, even if there is an appropriate amount of oxygen for respiration. <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B11"><sup>11</sup></xref> In other words, instead of developing a complete respiration process in the presence of adequate amounts of oxygen, cancer cells ferment and continue to mutate to preserve their tumoral domain. <xref ref-type="bibr" rid="B12"><sup>12</sup></xref>
				</p>
				<p>At the cellular level, tumors have survival advantages due to lactate secretion. <xref ref-type="bibr" rid="B4"><sup>4</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref> Lactic acid confers invasive properties to tumor cells, affecting the normal structure of tissues. <xref ref-type="bibr" rid="B15"><sup>15</sup></xref> Additionally, the expression of vascular endothelial growth factor and its receptor (VEGF and VEGFR, respectively) responds to different stimuli to generate new blood vessels from preexisting ones. <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref> VEGFα stimulates vascular endothelial cell growth, cell survival and proliferation regulated by the nuclear and mitochondrial action of the cell. Furthermore, VEGF and gene mutations leading to actívate metalloproteinases to degrade the extracellular matrix allow greater metastatic action. <xref ref-type="bibr" rid="B19"><sup>19</sup></xref> Recent studies suggest that VEGF can protect cells from apoptosis and increase their resistance to conventional chemotherapy and radiotherapy. <xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref>
				</p>
				<p>Similarly, metastasis is of great importance since most of cáncer deaths occur because primary cancer spreads to distant sites. In most cases, cancer patients with localized tumors have a better survival rate than patients with cancer and metastatic tumors. <xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B25"><sup>25</sup></xref> It is also suggested that the increase of oncogene mutations, tumor suppressor genes and enzymes of the glycolytic pathway and/or mitocondrial oxidative metabolism (Myc, Akt, p53, HIF1-α) allow to turn cáncer cells into efficient metastatic cells. <xref ref-type="bibr" rid="B3"><sup>3</sup></xref>
				</p>
				<p>The hypoxia-inducible factor (HIF-1) protein is normally activated in response to certain cellular crises, such as lack of oxygen. However, in the case of mitochondria with abnormal and tumor mechanisms, the expression of HIF-1 that is perpetuated in the presence of damage signs in the SDH gene is stimulated. This is caused by the cell following already established oncogenes guidelines to carry out a unique type of homeostasis for cancer and to supply high levels of glucose and oxygen to replicate itself without control. <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B26"><sup>26</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref>
				</p>
			</sec>
			<sec>
				<title>Variety of metabolic fuels for tumor cells</title>
				<p>A wide variety of metabolic fuels can be observed in tumor pathways, in which tumor cells are able to utilize different bioenergetic substrates, including glutamine, glucose, fatty acids, ketone bodies, and acetate. These substrates can be provided by the stromal cells in the microenvironment. <xref ref-type="bibr" rid="B28"><sup>28</sup></xref> Particularly, glutamine and glucose can provide building blocks for the synthesis of many biomolecules that allow the regulation of oncogenesis processes. It is worth mentioning that metabolic enzymes with mutations are found in several tumors and in the oncometabolites accumulated in different types of tumors. <xref ref-type="bibr" rid="B28"><sup>28</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref>
				</p>
				<p>Cancer cells also show increased demand for fatty acids other tan glutamine. <xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref> Fatty acids can be synthesized endogenously or taken from exogenous sources. For example, prostate tumors import less glucose than other tumors, <xref ref-type="bibr" rid="B31"><sup>31</sup></xref> therefore, β-oxidation of fatty acids is an important source of energy. <xref ref-type="bibr" rid="B32"><sup>32</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B33"><sup>33</sup></xref>
				</p>
				<p>Moreover, two recent studies showed that acetate is a bioenergetic substrate for glioblastoma and brain metastases. <xref ref-type="bibr" rid="B34"><sup>34</sup></xref> Catabolism in stromal and adipocyte cells provides fuel and building blocks for the anabolic growth of cancer cells through metabolic coupling. <xref ref-type="bibr" rid="B35"><sup>35</sup></xref>
				</p>
			</sec>
			<sec>
				<title>Cancer cells and independence</title>
				<p>In 2000 and 2011, Hanahan and Weinberg summarized an extensive research on cancer and the top 10 characteristics of cancer and its correlation with mitochondria (<xref ref-type="table" rid="t2">table 2</xref>). <xref ref-type="bibr" rid="B36"><sup>36</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B39"><sup>39</sup></xref> These authors describe how cancer cells can be stimulated by infectious phenomena, inflammation, viruses, toxic substances and other actions that allow the proliferation of anomalous cells.</p>
				<p>
					<table-wrap id="t2">
						<label>Table 2</label>
						<caption>
							<title>Top 10 characteristics of cancer and their correlation to mitochondria.</title>
						</caption>
						<graphic xlink:href="0120-0011-rfmun-66-01-00083-gt2.png"/>
						<table-wrap-foot>
							<fn id="TFN2">
								<p>Source: Own elaboration based on <xref ref-type="bibr" rid="B23"><sup>23</sup></xref>.</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
				<p>In these works, they emphasize that the centralist vision of cáncer has transcended the anomalous production of cellular mutations, and also consider that tumor evolution is based on the appearance of changes and the stress in the cellular ecosystem that induces the genome to instability and produces mutations, signal activations with erroneous sequences and mechanisms of evasion in the immune system. <xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B40"><sup>40</sup></xref>
				</p>
				<p>With this in mind, tumors develop when normal cells undergo genetic alterations that affect growth points. This results in a disproportionate growth that eventually leads to the onset of the disease. As premalignant cells evolve to cancer cells, the environment surrounding the tumor coevolves as well, creating a dynamic circuit of tumormicroenvironment interaction. <xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B40"><sup>40</sup></xref>
				</p>
				<p>Approximately 80% of cancers are carcinomas, that is, cancers that originate in the epithelial tissue, and their main support is the stroma, which nourishes, protects and supports the epithelial tissue. It could be said that stroma is the connective tissue that forms the framework of an organ, and includes the extracellular matrix and the cells that synthesize it (fibroblasts, endothelial cells, etc.). <xref ref-type="bibr" rid="B23"><sup>23</sup></xref>
				</p>
				<p>Cancer cells communicate with their environment while exchanging soluble molecules with the paracrine stroma, which turns stroma into the support of the tumor and, therefore, facilitates its progression. It is worth mentioning that the success of the tumor depends on its ability to survive in an inhospitable microenvironment. Besides stromal cells, inflammatory cells may also be found in this microenvironment. <xref ref-type="bibr" rid="B39"><sup>39</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B40"><sup>40</sup></xref>
				</p>
			</sec>
			<sec>
				<title>Why to continue research on mitochondria?</title>
				<p>Currently, cancer studies focus their efforts on finding a molecular mechanism that links mitochondrial mutations to tumor formation. Research seeks to increase the understanding of the molecular basis of cancer, with the purpose of finding new prevention, diagnosis and treatment methods for the disease.</p>
			</sec>
		</sec>
	</body>
	<back>
		<ack>
			<title>Acknowledgement </title>
			<p>None stated by the authors.</p>
		</ack>
		<ref-list>
			<title>References</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>1. Wallace DC. Mitochondria and cancer. <italic>Nat Rev Cancer</italic>. 2012;12(10):685-98. <ext-link ext-link-type="uri" xlink:href="http://doi.org/f376vb">http://doi.org/f376vb</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Wallace</surname>
							<given-names>DC</given-names>
						</name>
					</person-group>
					<article-title>Mitochondria and cancer</article-title>
					<source>Nat Rev Cancer</source>
					<year>2012</year>
					<volume>12</volume>
					<issue>10</issue>
					<fpage>685</fpage>
					<lpage>698</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/f376vb">http://doi.org/f376vb</ext-link>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>2. Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. <italic>Trends Cell Biol</italic>. 2000;10(9):369-77. <ext-link ext-link-type="uri" xlink:href="http://doi.org/cnbkgg">http://doi.org/cnbkgg</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Desagher</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Martinou</surname>
							<given-names>JC</given-names>
						</name>
					</person-group>
					<article-title>Mitochondria as the central control point of apoptosis</article-title>
					<source>Trends Cell Biol</source>
					<year>2000</year>
					<volume>10</volume>
					<issue>9</issue>
					<fpage>369</fpage>
					<lpage>377</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/cnbkgg">http://doi.org/cnbkgg</ext-link>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>3. Jäättelä M. Multiple cell death pathways as regulators of tumour initiation and progression. <italic>Oncogene</italic>. 2004;23(16):2746-56. <ext-link ext-link-type="uri" xlink:href="http://doi.org/dzmrm7">http://doi.org/dzmrm7</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jäättelä</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Multiple cell death pathways as regulators of tumour initiation and progression</article-title>
					<source>Oncogene</source>
					<year>2004</year>
					<volume>23</volume>
					<issue>16</issue>
					<fpage>2746</fpage>
					<lpage>2756</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/dzmrm7">http://doi.org/dzmrm7</ext-link>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>4. Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaría G, Kim H, <italic>et al</italic>. The bioenergetic signature of cancer: a marker of tumor progression. <italic>Cancer Res</italic>. 2002;62(22):6674-81.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Cuezva</surname>
							<given-names>JM</given-names>
						</name>
						<name>
							<surname>Krajewska</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>de Heredia</surname>
							<given-names>ML</given-names>
						</name>
						<name>
							<surname>Krajewski</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Santamaría</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Kim</surname>
							<given-names>H</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>The bioenergetic signature of cancer: a marker of tumor progression</article-title>
					<source>Cancer Res</source>
					<year>2002</year>
					<volume>62</volume>
					<issue>22</issue>
					<fpage>6674</fpage>
					<lpage>6681</lpage>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>5. Polyak K, Li Y, Zhu H, Lengauer C, Wilson JK, Markowitz SD, <italic>et al</italic>. Somatic mutations of the mitochondrial genome in human colorectal tumours. <italic>Nat Genet</italic>. 1998;20(3):291-3. <ext-link ext-link-type="uri" xlink:href="http://doi.org/fp74fd">http://doi.org/fp74fd</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Polyak</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Li</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Zhu</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Lengauer</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Wilson</surname>
							<given-names>JK</given-names>
						</name>
						<name>
							<surname>Markowitz</surname>
							<given-names>SD</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Somatic mutations of the mitochondrial genome in human colorectal tumours</article-title>
					<source>Nat Genet</source>
					<year>1998</year>
					<volume>20</volume>
					<issue>3</issue>
					<fpage>291</fpage>
					<lpage>293</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/fp74fd">http://doi.org/fp74fd</ext-link>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>6. Alam MM, Lal S, FitzGerald KE, Zhang L. A holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of diverse tumors. <italic>Clin Transl Med</italic>. 2016;5(1):3. <ext-link ext-link-type="uri" xlink:href="http://doi.org/chtw">http://doi.org/chtw</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Alam</surname>
							<given-names>MM</given-names>
						</name>
						<name>
							<surname>Lal</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>FitzGerald</surname>
							<given-names>KE</given-names>
						</name>
						<name>
							<surname>Zhang</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title>A holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of diverse tumors</article-title>
					<source>Clin Transl Med</source>
					<year>2016</year>
					<volume>5</volume>
					<issue>1</issue>
					<fpage>3</fpage>
					<lpage>3</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/chtw">http://doi.org/chtw</ext-link>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>7. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. <italic>J Gen Physiol</italic>. 1927;8(6):519-30. <ext-link ext-link-type="uri" xlink:href="http://doi.org/bjmdt2">http://doi.org/bjmdt2</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Warburg</surname>
							<given-names>O</given-names>
						</name>
						<name>
							<surname>Wind</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Negelein</surname>
							<given-names>E</given-names>
						</name>
					</person-group>
					<article-title>The metabolism of tumors in the body</article-title>
					<source>J Gen Physiol</source>
					<year>1927</year>
					<volume>8</volume>
					<issue>6</issue>
					<fpage>519</fpage>
					<lpage>530</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/bjmdt2">http://doi.org/bjmdt2</ext-link>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>8. Warburg O. On the origin of cancer cells. <italic>Science</italic>. 1956;123(3191):309-14. <ext-link ext-link-type="uri" xlink:href="http://doi.org/fj737q">http://doi.org/fj737q</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Warburg</surname>
							<given-names>O</given-names>
						</name>
					</person-group>
					<article-title>On the origin of cancer cells</article-title>
					<source>Science</source>
					<year>1956</year>
					<volume>123</volume>
					<issue>3191</issue>
					<fpage>309</fpage>
					<lpage>314</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/fj737q">http://doi.org/fj737q</ext-link>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>9. Simmons J.G. Doctors &amp; Discoveries. <italic>Boston</italic>: <italic>Houghton Mifflin Com</italic>; 2002.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Simmons</surname>
							<given-names>J.G</given-names>
						</name>
					</person-group>
					<source>Doctors &amp; Discoveries</source>
					<publisher-loc>Boston</publisher-loc>
					<publisher-name>Houghton Mifflin Com</publisher-name>
					<year>2002</year>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>10. Warburg O, Psener K, Negelein E. Üeber den Stoffwechsel der Tumoren. <italic>Biochem Z</italic>. 1924;152(1):319-44.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Warburg</surname>
							<given-names>O</given-names>
						</name>
						<name>
							<surname>Psener</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Negelein</surname>
							<given-names>E</given-names>
						</name>
					</person-group>
					<article-title>Üeber den Stoffwechsel der Tumoren</article-title>
					<source>Biochem Z</source>
					<year>1924</year>
					<volume>152</volume>
					<issue>1</issue>
					<fpage>319</fpage>
					<lpage>344</lpage>
				</element-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation>11. Vazquez A, Liu J, Zhu Y, Oltvai ZN. Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited. <italic>BMC Syst Biol</italic>. 2010;4:58. <ext-link ext-link-type="uri" xlink:href="http://doi.org/bvqgqr">http://doi.org/bvqgqr</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Vazquez</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Liu</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Zhu</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Oltvai</surname>
							<given-names>ZN</given-names>
						</name>
					</person-group>
					<article-title>Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited</article-title>
					<source>BMC Syst Biol</source>
					<year>2010</year>
					<volume>4</volume>
					<fpage>58</fpage>
					<lpage>58</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/bvqgqr">http://doi.org/bvqgqr</ext-link>
				</element-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation>12. Brunelle JK, Bell EL, Quesada NM, Veercauteren K, Tiranti V, Zeviani M, <italic>et al</italic>. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. <italic>Cell Metab</italic>. 2005;1(6):409-14. <ext-link ext-link-type="uri" xlink:href="http://doi.org/d2d9hx">http://doi.org/d2d9hx</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Brunelle</surname>
							<given-names>JK</given-names>
						</name>
						<name>
							<surname>Bell</surname>
							<given-names>EL</given-names>
						</name>
						<name>
							<surname>Quesada</surname>
							<given-names>NM</given-names>
						</name>
						<name>
							<surname>Veercauteren</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Tiranti</surname>
							<given-names>V</given-names>
						</name>
						<name>
							<surname>Zeviani</surname>
							<given-names>M</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation</article-title>
					<source>Cell Metab</source>
					<year>2005</year>
					<volume>1</volume>
					<issue>6</issue>
					<fpage>409</fpage>
					<lpage>414</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/d2d9hx">http://doi.org/d2d9hx</ext-link>
				</element-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation>13. Bertram JS. The molecular biology of cancer. <italic>Mol Asp Med</italic>. 2000;21(6):167-223. <ext-link ext-link-type="uri" xlink:href="http://doi.org/bh3qhx">http://doi.org/bh3qhx</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Bertram</surname>
							<given-names>JS</given-names>
						</name>
					</person-group>
					<article-title>The molecular biology of cancer</article-title>
					<source>Mol Asp Med</source>
					<year>2000</year>
					<volume>21</volume>
					<issue>6</issue>
					<fpage>167</fpage>
					<lpage>223</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/bh3qhx">http://doi.org/bh3qhx</ext-link>
				</element-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation>14. Kyle RA, Shampo MA. Otto Heinrich Warburg. <italic>Mayo Clin Proc</italic>. 1988;63(1):79. <ext-link ext-link-type="uri" xlink:href="http://doi.org/cmtd">http://doi.org/cmtd</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kyle</surname>
							<given-names>RA</given-names>
						</name>
						<name>
							<surname>Shampo</surname>
							<given-names>MA</given-names>
						</name>
					</person-group>
					<article-title>Otto Heinrich Warburg</article-title>
					<source>Mayo Clin Proc</source>
					<year>1988</year>
					<volume>63</volume>
					<issue>1</issue>
					<fpage>79</fpage>
					<lpage>79</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/cmtd">http://doi.org/cmtd</ext-link>
				</element-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation>15. Ramírez-Agudelo ME, Rojas-López M. La necrosis, un mecanismo regulado de muerte celular. <italic>IATREIA</italic>. 2010;23(2):166-77.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ramírez-Agudelo</surname>
							<given-names>ME</given-names>
						</name>
						<name>
							<surname>Rojas-López</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>La necrosis, un mecanismo regulado de muerte celular</article-title>
					<source>IATREIA</source>
					<year>2010</year>
					<volume>23</volume>
					<issue>2</issue>
					<fpage>166</fpage>
					<lpage>177</lpage>
				</element-citation>
			</ref>
			<ref id="B16">
				<label>16</label>
				<mixed-citation>16. Cuezva JM, Ortega AD, Willers I, Sanchez-Cenizo L, Aldea M, Sánchez-Aragó M. The tumor suppressor function of mitochondria: translation into the clinics. <italic>Biochim Biophys Acta</italic>. 2009;1792(12):114558. <ext-link ext-link-type="uri" xlink:href="http://doi.org/bgzqtz">http://doi.org/bgzqtz</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Cuezva</surname>
							<given-names>JM</given-names>
						</name>
						<name>
							<surname>Ortega</surname>
							<given-names>AD</given-names>
						</name>
						<name>
							<surname>Willers</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Sanchez-Cenizo</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Aldea</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Sánchez-Aragó</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>The tumor suppressor function of mitochondria: translation into the clinics</article-title>
					<source>Biochim Biophys Acta</source>
					<year>2009</year>
					<volume>1792</volume>
					<issue>12</issue>
					<fpage>114558</fpage>
					<lpage>114558</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/bgzqtz">http://doi.org/bgzqtz</ext-link>
				</element-citation>
			</ref>
			<ref id="B17">
				<label>17</label>
				<mixed-citation>17. Devita VT, Hellman S, Roseenberg SA. Cáncer: Principios y Práctica de Oncología. Vol 2. 7<sup>th</sup> ed. Philadelphia: Lippincott Williams &amp; Wilkins; 2005.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Devita</surname>
							<given-names>VT</given-names>
						</name>
						<name>
							<surname>Hellman</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Roseenberg</surname>
							<given-names>SA</given-names>
						</name>
					</person-group>
					<source>Cáncer: Principios y Práctica de Oncología</source>
					<volume>2</volume>
					<edition>7</edition>
					<publisher-loc>Philadelphia</publisher-loc>
					<publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
					<year>2005</year>
				</element-citation>
			</ref>
			<ref id="B18">
				<label>18</label>
				<mixed-citation>18. Martínez-Hezquerro JD, Herrera LA. Angiogénesis: VEGF/VEGFRs como blancos terapéuticos en el tratamiento contra el cáncer. <italic>Cancerología</italic>. 2006;1(1):83-96.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Martínez-Hezquerro</surname>
							<given-names>JD</given-names>
						</name>
						<name>
							<surname>Herrera</surname>
							<given-names>LA</given-names>
						</name>
					</person-group>
					<article-title>Angiogénesis: VEGF/VEGFRs como blancos terapéuticos en el tratamiento contra el cáncer</article-title>
					<source>Cancerología</source>
					<year>2006</year>
					<volume>1</volume>
					<issue>1</issue>
					<fpage>83</fpage>
					<lpage>96</lpage>
				</element-citation>
			</ref>
			<ref id="B19">
				<label>19</label>
				<mixed-citation>19. Saavedra-Torres JS, Zuñiga-Cerón LF, Freyre-Bernal SI, Muñoz-Ordoñez GW, Salguero C. El rol de VEGF en la angiogénesis fisiológica y tumoral. <italic>Medicina</italic>. 2017;39(3):190-209.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Saavedra-Torres</surname>
							<given-names>JS</given-names>
						</name>
						<name>
							<surname>Zuñiga-Cerón</surname>
							<given-names>LF</given-names>
						</name>
						<name>
							<surname>Freyre-Bernal</surname>
							<given-names>SI</given-names>
						</name>
						<name>
							<surname>Muñoz-Ordoñez</surname>
							<given-names>GW</given-names>
						</name>
						<name>
							<surname>Salguero</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>El rol de VEGF en la angiogénesis fisiológica y tumoral</article-title>
					<source>Medicina</source>
					<year>2017</year>
					<volume>39</volume>
					<issue>3</issue>
					<fpage>190</fpage>
					<lpage>209</lpage>
				</element-citation>
			</ref>
			<ref id="B20">
				<label>20</label>
				<mixed-citation>20. Duffy AM, Bouchier-Hayes DJ, Harmey JH. Vascular Endothelial Growth Factor (VEGF) and Its Role in Non-Endothelial Cells: Autocrine Signalling by VEGF. Firts. Austin: Bioscience; 200-2013.</mixed-citation>
				<element-citation publication-type="other">
					<person-group person-group-type="author">
						<name>
							<surname>Duffy</surname>
							<given-names>AM</given-names>
						</name>
						<name>
							<surname>Bouchier-Hayes</surname>
							<given-names>DJ</given-names>
						</name>
						<name>
							<surname>Harmey</surname>
							<given-names>JH</given-names>
						</name>
					</person-group>
					<source>Vascular Endothelial Growth Factor (VEGF) and Its Role in Non-Endothelial Cells: Autocrine Signalling by VEGF. Firts</source>
					<publisher-loc>Austin</publisher-loc>
					<publisher-name>Bioscience</publisher-name>
					<fpage>200</fpage>
					<lpage>2013</lpage>
				</element-citation>
			</ref>
			<ref id="B21">
				<label>21</label>
				<mixed-citation>21. Reichardt LF, Tomaselli KJ. Extracellular matrix molecules and their receptors: functions in neural development. <italic>Annu Rev Neurosci</italic>. 1991;14:531-70. <ext-link ext-link-type="uri" xlink:href="http://doi.org/frrkc4">http://doi.org/frrkc4</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Reichardt</surname>
							<given-names>LF</given-names>
						</name>
						<name>
							<surname>Tomaselli</surname>
							<given-names>KJ</given-names>
						</name>
					</person-group>
					<article-title>Extracellular matrix molecules and their receptors: functions in neural development</article-title>
					<source>Annu Rev Neurosci</source>
					<year>1991</year>
					<volume>14</volume>
					<fpage>531</fpage>
					<lpage>570</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/frrkc4">http://doi.org/frrkc4</ext-link>
				</element-citation>
			</ref>
			<ref id="B22">
				<label>22</label>
				<mixed-citation>22. Mandal A. ¿Cuál es Metástasis? London: News Medica Life Sciences &amp; Medicine; 2014.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Mandal</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<source>Cuál es Metástasis</source>
					<publisher-loc>London</publisher-loc>
					<publisher-name>News Medica Life Sciences &amp; Medicine</publisher-name>
					<year>2014</year>
				</element-citation>
			</ref>
			<ref id="B23">
				<label>23</label>
				<mixed-citation>23. Saavedra-Torres JS, Zúñiga-Cerón LF, Vásquez-López JA, Navia-Amézquita CA, Mosquera-Sánchez LP, Freyre-Bernal SI. La matriz extracelular: un ecosistema influyente en la forma y comportamiento de las células. <italic>Morfolia</italic>. 2015;7(1):12-35.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Saavedra-Torres</surname>
							<given-names>JS</given-names>
						</name>
						<name>
							<surname>Zúñiga-Cerón</surname>
							<given-names>LF</given-names>
						</name>
						<name>
							<surname>Vásquez-López</surname>
							<given-names>JA</given-names>
						</name>
						<name>
							<surname>Navia-Amézquita</surname>
							<given-names>CA</given-names>
						</name>
						<name>
							<surname>Mosquera-Sánchez</surname>
							<given-names>LP</given-names>
						</name>
						<name>
							<surname>Freyre-Bernal</surname>
							<given-names>SI</given-names>
						</name>
					</person-group>
					<article-title>La matriz extracelular: un ecosistema influyente en la forma y comportamiento de las células</article-title>
					<source>Morfolia</source>
					<year>2015</year>
					<volume>7</volume>
					<issue>1</issue>
					<fpage>12</fpage>
					<lpage>35</lpage>
				</element-citation>
			</ref>
			<ref id="B24">
				<label>24</label>
				<mixed-citation>24. Kuo TH, Kubota T, Watanabe M, Furukawa T, Teramoto T, Ishibiki K, <italic>et al</italic>. Liver colonization competence governs colon cancer matastasis. <italic>Proc Natl Acad Sci U S A</italic>. 1995;92(26):12085-9.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kuo</surname>
							<given-names>TH</given-names>
						</name>
						<name>
							<surname>Kubota</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Watanabe</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Furukawa</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Teramoto</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Ishibiki</surname>
							<given-names>K</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Liver colonization competence governs colon cancer matastasis</article-title>
					<source>Proc Natl Acad Sci U S A</source>
					<year>1995</year>
					<volume>92</volume>
					<issue>26</issue>
					<fpage>12085</fpage>
					<lpage>12089</lpage>
				</element-citation>
			</ref>
			<ref id="B25">
				<label>25</label>
				<mixed-citation>25. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. <italic>Nature</italic>. 2011;473(7347):298-307. <ext-link ext-link-type="uri" xlink:href="http://doi.org/b95kmv">http://doi.org/b95kmv</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Carmeliet</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Jain</surname>
							<given-names>RK</given-names>
						</name>
					</person-group>
					<article-title>Molecular mechanisms and clinical applications of angiogenesis</article-title>
					<source>Nature</source>
					<year>2011</year>
					<volume>473</volume>
					<issue>7347</issue>
					<fpage>298</fpage>
					<lpage>307</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/b95kmv">http://doi.org/b95kmv</ext-link>
				</element-citation>
			</ref>
			<ref id="B26">
				<label>26</label>
				<mixed-citation>26. Marín-Hernández A. El factor inducido por la hipoxia-1 (HIF-1) y la glucólisis en las células tumorales. <italic>REB</italic>. 2009;28(2):42-51.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Marín-Hernández</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>El factor inducido por la hipoxia-1 (HIF-1) y la glucólisis en las células tumorales</article-title>
					<source>REB</source>
					<year>2009</year>
					<volume>28</volume>
					<issue>2</issue>
					<fpage>42</fpage>
					<lpage>51</lpage>
				</element-citation>
			</ref>
			<ref id="B27">
				<label>27</label>
				<mixed-citation>27. Simonnet H, Alazard N, Pfeiffer K, Gallou C, Bérud C, Demont J, <italic>et al</italic>. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. <italic>Carcinogenesis</italic>. 2002;23(5):759-68.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Simonnet</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Alazard</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Pfeiffer</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Gallou</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Bérud</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Demont</surname>
							<given-names>J</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma</article-title>
					<source>Carcinogenesis</source>
					<year>2002</year>
					<volume>23</volume>
					<issue>5</issue>
					<fpage>759</fpage>
					<lpage>768</lpage>
				</element-citation>
			</ref>
			<ref id="B28">
				<label>28</label>
				<mixed-citation>28. Bergström J, Fürst P, Norée LO, Vinnars E. Intracellular free amino acid concentration in human muscle tissue. <italic>J Appl Physiol</italic>. 1974;36(6):693-7. <ext-link ext-link-type="uri" xlink:href="http://doi.org/chtx">http://doi.org/chtx</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Bergström</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Fürst</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Norée</surname>
							<given-names>LO</given-names>
						</name>
						<name>
							<surname>Vinnars</surname>
							<given-names>E</given-names>
						</name>
					</person-group>
					<article-title>Intracellular free amino acid concentration in human muscle tissue</article-title>
					<source>J Appl Physiol</source>
					<year>1974</year>
					<volume>36</volume>
					<issue>6</issue>
					<fpage>693</fpage>
					<lpage>697</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/chtx">http://doi.org/chtx</ext-link>
				</element-citation>
			</ref>
			<ref id="B29">
				<label>29</label>
				<mixed-citation>29. Wise DR, Ward PS, Shay JE, Cross JR, Gruber JJ, Sachdeva UM, <italic>et al</italic>. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. <italic>Proc Natl Acad Sci U SA</italic>. 2011;108(49):19611-6. <ext-link ext-link-type="uri" xlink:href="http://doi.org/ddpjzn">http://doi.org/ddpjzn</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Wise</surname>
							<given-names>DR</given-names>
						</name>
						<name>
							<surname>Ward</surname>
							<given-names>PS</given-names>
						</name>
						<name>
							<surname>Shay</surname>
							<given-names>JE</given-names>
						</name>
						<name>
							<surname>Cross</surname>
							<given-names>JR</given-names>
						</name>
						<name>
							<surname>Gruber</surname>
							<given-names>JJ</given-names>
						</name>
						<name>
							<surname>Sachdeva</surname>
							<given-names>UM</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability</article-title>
					<source>Proc Natl Acad Sci U SA</source>
					<year>2011</year>
					<volume>108</volume>
					<issue>49</issue>
					<fpage>19611</fpage>
					<lpage>19616</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/ddpjzn">http://doi.org/ddpjzn</ext-link>
				</element-citation>
			</ref>
			<ref id="B30">
				<label>30</label>
				<mixed-citation>30. Zaidi N, Lupien L, Kuemmerle NB, Kinlaw WB, Swinne JV, Smans K. Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. <italic>Prog Lipid Res</italic>. 2013;52(4):585-9. <ext-link ext-link-type="uri" xlink:href="http://doi.org/f5kv3t">http://doi.org/f5kv3t</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Zaidi</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Lupien</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Kuemmerle</surname>
							<given-names>NB</given-names>
						</name>
						<name>
							<surname>Kinlaw</surname>
							<given-names>WB</given-names>
						</name>
						<name>
							<surname>Swinne</surname>
							<given-names>JV</given-names>
						</name>
						<name>
							<surname>Smans</surname>
							<given-names>K</given-names>
						</name>
					</person-group>
					<article-title>Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids</article-title>
					<source>Prog Lipid Res</source>
					<year>2013</year>
					<volume>52</volume>
					<issue>4</issue>
					<fpage>585</fpage>
					<lpage>589</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/f5kv3t">http://doi.org/f5kv3t</ext-link>
				</element-citation>
			</ref>
			<ref id="B31">
				<label>31</label>
				<mixed-citation>31. Price DT, Coleman RE, Liao RP, Robertsn CN, Polascik TJ, De- Grad TR. Comparison of [18 F] fluorocholine and [18 F] fluorodeoxy-glucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. <italic>J Urol</italic>. 2002;168(1):273-80. <ext-link ext-link-type="uri" xlink:href="http://doi.org/cx77j9">http://doi.org/cx77j9</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Price</surname>
							<given-names>DT</given-names>
						</name>
						<name>
							<surname>Coleman</surname>
							<given-names>RE</given-names>
						</name>
						<name>
							<surname>Liao</surname>
							<given-names>RP</given-names>
						</name>
						<name>
							<surname>Robertsn</surname>
							<given-names>CN</given-names>
						</name>
						<name>
							<surname>Polascik</surname>
							<given-names>TJ</given-names>
						</name>
						<name>
							<surname>De- Grad</surname>
							<given-names>TR</given-names>
						</name>
					</person-group>
					<article-title>Comparison of [18 F] fluorocholine and [18 F] fluorodeoxy-glucose for positron emission tomography of androgen dependent and androgen independent prostate cancer</article-title>
					<source>J Urol</source>
					<year>2002</year>
					<volume>168</volume>
					<issue>1</issue>
					<fpage>273</fpage>
					<lpage>280</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/cx77j9">http://doi.org/cx77j9</ext-link>
				</element-citation>
			</ref>
			<ref id="B32">
				<label>32</label>
				<mixed-citation>32. Liu Y, Zuckier LS, Ghesani NV. Dominant uptake of fatty acid over glucose by prostate cells: a potential new diagnostic and therapeutic approach. <italic>Anticancer Res</italic>. 2010;30(2):369-74.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Liu</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Zuckier</surname>
							<given-names>LS</given-names>
						</name>
						<name>
							<surname>Ghesani</surname>
							<given-names>NV</given-names>
						</name>
					</person-group>
					<article-title>Dominant uptake of fatty acid over glucose by prostate cells: a potential new diagnostic and therapeutic approach</article-title>
					<source>Anticancer Res</source>
					<year>2010</year>
					<volume>30</volume>
					<issue>2</issue>
					<fpage>369</fpage>
					<lpage>374</lpage>
				</element-citation>
			</ref>
			<ref id="B33">
				<label>33</label>
				<mixed-citation>33. Zha S, Ferdinandusse S, Hicks JL, Denis S, Dunn TA, Wanders RJ, <italic>et al</italic>. Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer. <italic>Prostate</italic>. 2005;63(4):316-23. <ext-link ext-link-type="uri" xlink:href="http://doi.org/ftgnnb">http://doi.org/ftgnnb</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Zha</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Ferdinandusse</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Hicks</surname>
							<given-names>JL</given-names>
						</name>
						<name>
							<surname>Denis</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Dunn</surname>
							<given-names>TA</given-names>
						</name>
						<name>
							<surname>Wanders</surname>
							<given-names>RJ</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer</article-title>
					<source>Prostate</source>
					<year>2005</year>
					<volume>63</volume>
					<issue>4</issue>
					<fpage>316</fpage>
					<lpage>323</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/ftgnnb">http://doi.org/ftgnnb</ext-link>
				</element-citation>
			</ref>
			<ref id="B34">
				<label>34</label>
				<mixed-citation>34. Comerford SA, Huang Z, Du X, Wang Y, Cai L, Witkiewicz AK, <italic>et al</italic>. Acetate dependence of tumors. <italic>Cell</italic>. 2014;159(7):1591-602. <ext-link ext-link-type="uri" xlink:href="http://doi.org/f6wrwh">http://doi.org/f6wrwh</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Comerford</surname>
							<given-names>SA</given-names>
						</name>
						<name>
							<surname>Huang</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Du</surname>
							<given-names>X</given-names>
						</name>
						<name>
							<surname>Wang</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Cai</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Witkiewicz</surname>
							<given-names>AK</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Acetate dependence of tumors</article-title>
					<source>Cell</source>
					<year>2014</year>
					<volume>159</volume>
					<issue>7</issue>
					<fpage>1591</fpage>
					<lpage>1602</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/f6wrwh">http://doi.org/f6wrwh</ext-link>
				</element-citation>
			</ref>
			<ref id="B35">
				<label>35</label>
				<mixed-citation>35. Martinez-Outschoorn UE, Lisanti MP, Sotgia F. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. <italic>Semin Cancer Biol</italic>. 2014;25:47-60. <ext-link ext-link-type="uri" xlink:href="http://doi.org/f52594">http://doi.org/f52594</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Martinez-Outschoorn</surname>
							<given-names>UE</given-names>
						</name>
						<name>
							<surname>Lisanti</surname>
							<given-names>MP</given-names>
						</name>
						<name>
							<surname>Sotgia</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<article-title>Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth</article-title>
					<source>Semin Cancer Biol</source>
					<year>2014</year>
					<volume>25</volume>
					<fpage>47</fpage>
					<lpage>60</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/f52594">http://doi.org/f52594</ext-link>
				</element-citation>
			</ref>
			<ref id="B36">
				<label>36</label>
				<mixed-citation>36. Hanahan D, Weinberg RA. The Hallmarks of Cancer. <italic>Cell</italic>. 2000; 100(1):57-70. <ext-link ext-link-type="uri" xlink:href="http://doi.org/bm35gq">http://doi.org/bm35gq</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hanahan</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Weinberg</surname>
							<given-names>RA</given-names>
						</name>
					</person-group>
					<article-title>The Hallmarks of Cancer</article-title>
					<source>Cell</source>
					<year>2000</year>
					<volume>100</volume>
					<issue>1</issue>
					<fpage>57</fpage>
					<lpage>70</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/bm35gq">http://doi.org/bm35gq</ext-link>
				</element-citation>
			</ref>
			<ref id="B37">
				<label>37</label>
				<mixed-citation>37. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. <italic>Cell</italic>. 2011;144(5):646-74. <ext-link ext-link-type="uri" xlink:href="http://doi.org/b6snj3">http://doi.org/b6snj3</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hanahan</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Weinberg</surname>
							<given-names>RA</given-names>
						</name>
					</person-group>
					<article-title>Hallmarks of cancer: the next generation</article-title>
					<source>Cell</source>
					<year>2011</year>
					<volume>144</volume>
					<issue>5</issue>
					<fpage>646</fpage>
					<lpage>674</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://doi.org/b6snj3">http://doi.org/b6snj3</ext-link>
				</element-citation>
			</ref>
			<ref id="B38">
				<label>38</label>
				<mixed-citation>38. Cascales-Angosto M, Álvarez-Gómez JA. Metaloproteinasas, matriz extracelular y cáncer. <italic>An. R. Acad. Nac. Farm</italic>. 2010;76(1):59-84.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Cascales-Angosto</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Álvarez-Gómez</surname>
							<given-names>JA</given-names>
						</name>
					</person-group>
					<article-title>Metaloproteinasas, matriz extracelular y cáncer</article-title>
					<source>An. R. Acad. Nac. Farm</source>
					<year>2010</year>
					<volume>76</volume>
					<issue>1</issue>
					<fpage>59</fpage>
					<lpage>84</lpage>
				</element-citation>
			</ref>
			<ref id="B39">
				<label>39</label>
				<mixed-citation>39. González-Ávila G, González A, Delgado J, Gutiérrez-González LH. Participación de las metaloproteasas de matriz en la progresión del cáncer. <italic>Rev Inst Nal Enf Resp Mex</italic>. 2009;22(4):328-36.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>González-Ávila</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>González</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Delgado</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Gutiérrez-González</surname>
							<given-names>LH</given-names>
						</name>
					</person-group>
					<article-title>Participación de las metaloproteasas de matriz en la progresión del cáncer</article-title>
					<source>Rev Inst Nal Enf Resp Mex</source>
					<year>2009</year>
					<volume>22</volume>
					<issue>4</issue>
					<fpage>328</fpage>
					<lpage>336</lpage>
				</element-citation>
			</ref>
			<ref id="B40">
				<label>40</label>
				<mixed-citation>40. Vivas D, Inga R, Yarlequé A. Uso potencial de componentes del veneno de serpiente en el tratamiento del cáncer. <italic>Rev Peru Med Exp Salud Publica</italic>. 2012;29(3):396-401.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Vivas</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Inga</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Yarlequé</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Uso potencial de componentes del veneno de serpiente en el tratamiento del cáncer</article-title>
					<source>Rev Peru Med Exp Salud Publica</source>
					<year>2012</year>
					<volume>29</volume>
					<issue>3</issue>
					<fpage>396</fpage>
					<lpage>401</lpage>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="other" id="fn1">
				<label>Freyre-Bernal SI, Saavedra-Torres JS, Zúñiga-Cerón LF, Díaz-Córdoba WJ, Pinzón-Fernández MV.</label>
				<p> Cancer and mitochondrial function. Rev. Fac. Med. 2018; 66(1):83-6. English. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.15446/revfacmed.v66n1.59898">http://dx.doi.org/10.15446/revfacmed.v66n1.59898</ext-link>.</p>
			</fn>
		</fn-group>
		<fn-group>
			<fn fn-type="other" id="fn2">
				<label>Freyre-Bernal SI, Saavedra-Torres JS, Zúñiga-Cerón LF, Díaz-Córdoba WJ, Pinzón-Fernández MV.</label>
				<p> [El cáncer en la función mitocondrial]. Rev. Fac. Med. 2018; 66(1):83-6. English. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.15446/revfacmed.v66n1.59898">http://dx.doi.org/10.15446/revfacmed.v66n1.59898</ext-link>. </p>
			</fn>
		</fn-group>
		<fn-group>
			<fn fn-type="other" id="fn3">
				<label>Conflict of interests</label>
				<p> None stated by the authors.</p>
			</fn>
		</fn-group>
		<fn-group>
			<fn fn-type="other" id="fn4">
				<label>Funding</label>
				<p> None stated by the authors.</p>
			</fn>
		</fn-group>
	</back>
</article>